
Albertsons reported better-than-expected Q4 earnings per share (EPS) and EBITDA, but revenue fell short due to ongoing competitive pressures impacting top-line growth. The company raised its dividend by 13% and announced a $2 billion stock buyback, signaling confidence in future earnings despite an $86 million annual cash drag from an opioid settlement. Digital sales grew 21% year-over-year, supporting a modest but sustained growth outlook in a changing retail environment. While valuation models suggest the stock is undervalued, high leverage and inconsistent revenue growth make it a speculative buy for long-term investors.